Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fucoidan for eradication of Helicobacter pylori
ChiCTR2400081499Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Mar 2024
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fucoidan in Helicobacter pylori infection, sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Helicobacter pylori eradication by 13C urea breath test. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
fucoidan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2400081499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081499.